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Background: Nitric oxide-mediated endothelium-dependent relaxation is attenuated in 
pulmonary artery segments from monocrotaline (MCT)-induced pulmonary hypertensive rats. 
However, the influence of the endothelium on adrenergic neurotransmission in the rat 
pulmonary artery has not been investigated. The aim of the present study was to investigate the 
effect of the endothelium on electrical field stimulation (EFS)-induced excitatory responses of 
pulmonary artery segments from pulmonary hypertensive rats. Methods: Pulmonary 
hypertension was induced in rats with a single dose of monocrotaline (60 mg/kg) and 21 days 
later, arterial rings were set up for isometric tension recording. EFS-induced contractions were 
recorded in the presence or absence of drugs.  Results: Electrical field stimulation (EFS) 
induced frequency-dependent contractions in artery segments from control rats and these 
contractions were not affected by removing the endothelium. L-NAME (10
-4
 M), a non-
selective NO synthase inhibitor, but not 7-NI, a selective neuronal NO synthase inhibitor, 
potentiated EFS-induced contractions. In addition, L-NAME had no effect on EFS-induced 
contractions in artery segments without the endothelium indicating a role for endothelium-
derived NO in modulating adrenergic neurotransmission in the pulmonary artery. EFS also 
induced frequency-dependent contractions of artery segments from pulmonary hypertensive 
rats. These contractions, expressed relative to KCl-induced contractions, were greater in artery 
segments from pulmonary hypertensive rats.  L-NAME (10
-4
 M) potentiated EFS-induced 
contractions of artery segments from MCT-treated rats and did not discriminate between artery 
segments from control and MCT-treated rats. L-NAME potentiated noradrenaline-induced 
contractions in artery segments from both groups indicating that the effect of L-NAME was 
mediated post-junctionally. Conclusion: Monocrotaline-induced pulmonary hypertension is 
associated with enhanced contractile response to EFS In addition, the modulatory effect of 
endothelial nitric oxide is unaltered in artery segments from pulmonary hypertensive rats.  
 




Pulmonary hypertension (PH) is associated with 
decreased vascular compliance, elevated pulmonary 
artery pressure, right heart failure and eventually,  
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death. It is characterized by vasoconstriction of the 
pulmonary arteries, vascular remodeling and structural 
changes resulting from smooth muscle proliferation and 
migration (Salvi, 1999). Endothelial dysfunction is a 
prominent feature of pulmonary hypertension and 
several studies have documented decreased 
endothelium-dependent nitric oxide (NO)-mediated 
vascular smooth muscle relaxation in various models of 
pulmonary hypertension (Dinh-Xuan et al., 1990; 
Adnot et al., 1991; Nakazawa et al., 1999; Ito et al., 
2000).  
The pulmonary circulation is richly innervated by 
sympathetic nerves (Boe and Simonsson, 1980; Colucci 
et al, 1981; Salvi, 1999). It has been reported that α1-
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adrenoceptor antagonists reduce pulmonary vascular 
resistance (Colucci et al, 1981) which would explain 
why α1-adrenergic antagonists have been used 
successful in the treatment of pulmonary hypertension 
(Kanemoto et al., 1984; Lewczuk et al., 1992; Alpert et 
al., 1994; Inoue et al., 1994; Salvi, 1999; Ishikawa et 
al., 2009). The fact that chemical sympathectomy 
reduced right ventricular hypertrophy induced by 
monocrotaline in rats (Tucker et al., 1983) would 
support a role for enhanced sympathetic nerve activity 
in the pathobiology of pulmonary hypertension. Later 
studies have shown that noradrenaline, acting on α1-
adrenoceptors plays a significant role in remodeling of 
the pulmonary artery (Faber et al., 2006; 2007) in 
pulmonary hypertension. Despite all these observations, 
the possible role of the sympathetic nervous system in 
the pathobiology of pulmonary hypertension has not 
received much consideration. This is probably because 
of the variable results obtained with respect to the 
circulating levels of noradrenaline (Haneda et al., 1983; 
Nagaya et al., 2000; Nootens et al., 1995; Richards et 
al., 1990; Velez-Roa et al., 2004). However, using 
microneurographic techniques, Velez-Roa et al. (2004) 
have reported elevated sympathetic nerve activity in 
patients with advanced pulmonary hypertension. Mak 
et al. (2011) have made similar observations using 
radiotracer techniques to measure cardiac and total 
body sympathetic activity in patients with cardiac 
failure. To date, most of the studies on vascular 
reactivity in pulmonary hypertension have focused 
mainly on agonist-induced (contraction/relaxation) 
responses and not much has been done on the effect of 
pulmonary hypertension on electrical field stimulation-
induced contractions of the pulmonary artery. The main 
objective of the present study was therefore to 
investigate the effect of monocrotaline-induced 
pulmonary hypertension in rats on the excitatory 
response of the pulmonary artery to electrical field 
stimulation. Included in this study was the possible role 




Adult male rats (200-300 g) were used in this 
investigation. These rats were bred and maintained 
under internationally accepted conditions in the animal 
resource center of the Faculty of Medicine, Kuwait 
University. This study was approved by the institution's 
research ethics committee. The rats had free access to 
food and water.  
 
Induction of pulmonary hypertension:  
Pulmonary hypertension was induced by treating the 
rats with a single intraperitoneal injection of 
monocrotaline (60 mg/kg) and used 3 wks later. Age-
matched rats, not treated with monocrotaline, were used 
as controls.  
 
Isolation and preparation of arterial ring segment:  
On the day of the experiments, each rat was 
anaesthetized with sodium pentobarbitone (35 mg/kg 
i.v). The thoracic cavity was opened up and the lungs 
together with the heart were removed en-bloc and 
placed in a Petri dish containing cold Krebs' solution. 
After carefully isolating the extralobar pulmonary 
arteries, the heart was weighed and the ratio of heart 
weight to body weight was used as an index of cardiac 
hypertrophy. The pulmonary artery segments were then 
carefully cleared of any adhering connective tissues 
without destroying the endothelium. However, in some 
experiments, the endothelium was removed by gently 
rubbing the artery lumen with fine wire to examine the 
role of the endothelium on vascular reactivity. In these 
instances, endothelial denudation was confirmed by the 
inability of acetylcholine (10
-6
 M) to relax artery 
segments contracted with noradrenaline (10
-7
 M). 
Artery ring segments (3-4 mm in length) were set up in 
25.0 ml tissue baths containing Krebs’ solution (NaCl, 
119; KCl, 4.7; NaHCO3, 25; KH2PO4, 1.2; MgSO4, 1.2; 
CaCl2, 2.5 and glucose, 11 mM) at 37oC. The solution 
was continuously gassed with a 5% CO2/95% O2 
mixture and the pH was approximately 7.4. 
Desipramine (10
-7
 M) and propranolol (10
-6
 M) were 
included in the Krebs' solution to block neuronal uptake 
and -adrenoceptors respectively. The preparations 
were allowed to equilibrate under a resting tension of 
1.0 g for up to 60 min during which the bath fluid was 
changed at least once. Isometric contractions were 
recorded through dynamometer UF1 transducers on a 
Lectromed 4-channel polygraph (MultiTrace 4P). After 
the period of equilibration, KCl (80 mM) was added to 
the bath to test for tissue viability. This concentration 
of KCl was repeated after 30 min. The tissues were 
then washed repeatedly over the next 30 min period.  
 
Electrical field stimulation.  
The tissues were set up between two platinum 
electrodes for electrical stimulation. They were 
stimulated using square wave pulses (pulse duration 0.5 
ms, supramaximal voltage of 70 V for 20 s). The 
preparations were allowed to equilibrate under a resting 
tension of 1.0 g for up to 60 min during which the bath 
fluid was changed at least once. Isometric contractions 
were recorded through dynamometer UF1 transducers 
on a Lectromed 4-channel polygraph (MultiTrace 4P). 
After the period of equilibration, KCl was added to the 
bath and the contraction was recorded. At the peak of 
the contractions, the tissues were washed and allowed 
to return to the baseline. KCl was repeated after 30 
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min. The tissues were then washed repeatedly over the 
next 30 min period.  
Two consecutive frequency-response curves were 
separated by at least 60 min. EFS-induced (1-20Hz for 
15sec) contractions were expressed relative to KCl-
induced contractions.  
 
Effect of phentolamine on the contractile responses to 
EFS 
In order to determine the adrenergic nature of the 
response to electric field stimulation (EFS), the 
contractile responses to EFS were obtained in the 
absence and presence of phentolamine, a non-selective 
α-adrenoceptor blocker. After obtaining control 
frequency-response curve, phentolamine (10
-6
M) was 
added to the bath and allowed to equilibrate with the 
tissues for 30 minutes before the frequency- response 
curve was re-established.  
 
Effect of endothelial and neuronal NO on the 
contractile responses to EFS 
In order to study the influence of neuronal NO on the 
contractile responses to EFS, frequency-response 
curves for EFS were obtained in the absence and 
presence of L-nitroarginine methyl ester (L-NAME), a 
non-selective nitric oxide synthase (NOS) inhibitor, 
from endothelium-denuded ring segments of the 
pulmonary artery of control rats. After obtaining the 
control frequency-response curve for EFS, L-NAME 
(10
-4
M) was added to the bath and allowed to 
equilibrate with the tissues for 20 minutes before the 
EFS- response curve was re-established.  In another 
experiment, the endothelium of the ring segments of the 
PA of control rats was kept intact and the frequency-
response curves for EFS were obtained in the absence 
and presence of 7-nitroindazole (7-NI), a neuronal NOS 
inhibitor, and L-NAME. After obtaining the control 
frequency-response curve for EFS, 7-NI (10
-5
 M) was 
added to the bath and allowed to equilibrate for 20 min 
before EFS-response curve was re-established.  After 
obtaining EFS response curves in the presence of 7-NI, 
L-NAME (10
-4
 M) was added to the bath and allowed 
to equilibrate for 20 min before EFS-response curve 
was re-established. EFS-induced contractile responses 
in the presence of L-NAME, 7-NI or both were 
expressed relative to the maximum response in the 
absence of these agents. In order to determine the effect 
of PH on the NO-mediated changes in the contractile 
responses to EFS, frequency-response curves for EFS 
were obtained in the absence and presence of 7-NI and 
L-NAME in both control and monocrotaline-treated 
rats.  
 
Effect of L-NAME on the contractile response to 
noradrenaline 
The effect of L-NAME on noradrenaline-induced 
contraction of the pulmonary artery segments was also 
investigated as follows: after establishing control 
concentration-response curve to noradrenaline, L-
NAME (10
-4
M) was added to the bath and allowed to 
equilibrate with the tissue for 30 min. This was 
followed by adding increasing concentrations of 
noradrenaline to the bath to establish another 
concentration-response curve. In this series, the 
response to noradrenaline in the presence of L-NAME 
was expressed as a percentage of the maximum 




The following compounds were used in this study: 
crotaline (monocrotaline), phentolamine mesylate, 
carbamoylcholine chloride (carbachol), desipramine 
hydrochloride, (-)-noradrenaline (arterenol) bitartrate, 
()-propranolol hydrochloride, Nw-nitro-L-arginine 
methyl ester hydrochloride (L-NAME) and 7-
nitroindazole (7-NI).  All the compounds with the 
exception of 7-NI (Research Biochemicals Inc, MA) 
were obtained from Sigma chemicals (St. Louis, MO). 
Stock solution of monocrotaline was prepared as 
follows: 150 mg of monocrotaline was dissolved in 1.0 
ml of 1 N HCl and 2.0 ml of distilled water was added 
and the pH was adjusted to 7.0 with NaOH. Thereafter, 
the volume was made up to 5.0 ml with distilled water 
to give a concentration of 30 mg/ml. Stock solutions of 
all other compounds were made in distilled water.  
 
Statistical analysis 
 All graphs were analyzed using GraphPad Prism 
software. Data are presented as mean± S.E.M of 'n' 
observations where ‘n’ represents the number of rats. 
Where necessary, differences between mean values 
were tested for significance using student's t test. 
Differences were assumed to be significant when P < 
0.05. 
   
RESULTS 
Heart weight to body weight ratio increased from 
3.19±0.08 (n = 10) in control rats to 3.99±0.17 (n = 14) 
3 weeks after treatment with monocrotaline. These 
values were significantly (P<0.05) different from each 




Electrical stimulation of the rat pulmonary artery 
produced frequency-dependent contractions. The 
contractions started during the period of stimulation 
and in most cases (especially at the higher frequencies) 
continued for a short time post-stimulation. The 
contractions were reproducible as consecutive 
frequency-response curves could be established and 
tachyphylaxis was not observed in any of the 
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preparations. The electrically-induced contractions 
were almost abolished (not shown) by phentolamine 
(10
-6
 M) indicating that they were predominantly 
adrenergic in nature. EFS-induced contraction was 
greater in pulmonary artery segments from MCT-
treated rats. This was characterized by a leftward shift 
of the frequency-response curve. However, there was 
no significant (p>0.05) difference in the maximum 




EFS-induced contractions of pulmonary artery ring segments 
isolated from control () and monocrotaline-treated 
pulmonary hypertensive rats (). Each point on the graph is 
the mean  S.E.M of 5 experiments. * - significantly 
different p < 0.05 
 
 




 M) had no effect on the resting tone of 
pulmonary artery segments from control rats. It 
however significantly enhanced EFS-induced 
contractions at all frequencies studied (Figure 2). 
Removal of the endothelium had no effect on the basal 
tone of the preparation or as shown in Figure 3, on the 
response of the artery segments to EFS. Under this 
condition, L-NAME (10
-4
 M) had no effect on EFS-
induced contraction of the artery segments. The 
neuronal nitric oxide inhibitor, 7-NI had no effect on 
the basal tone of the preparation and as shown in Figure 
4, also did not potentiate response of the artery 
segments to EFS.  
 
Effect of monocrotaline-induced pulmonary 
hypertension on the modulatory effect of NO 
L-NAME (10
-4
 M) produced a slight increase in basal 
tone of pulmonary artery segments from 
monocrotaline-treated rats. This contraction amounted 
to approximately 5% of the response to KCl. L-NAME 
(10
-4
 M) potentiated EFS-induced contractions of 







Effect of L-NAME (10
-4
M), a non-selective inhibitor of 
nitric oxide synthase, on EFS-induced contractions of 
pulmonary artery ring segments isolated from control (A) 
and monocrotaline-treated pulmonary hypertensive rats (B). 
 and  represent EFS-induced contractions in the absence 
and in the presence of L-NAME, respectively. Each point on 
the graph is the mean  S.E.M of 4 (monocrotaline-treated 
rats) and 10 (control rats) experiments. * - significantly 






EFS-induced contractions of pulmonary artery ring segments 
with () and without () the endothelium (A, n = 5). L-
NAME () had no effect on EFS-induced contractions of 
pulmonary artery ring segments without the endothelium (B, 
n = 4).  
 
As shown in Figure 2, L-NAME (10
-4
 M) did not 
differentiate between artery segments from control and 
MCT-treated rats.  The neuronal nitric oxide inhibitor, 
7-NI had no effect on the basal tone of the artery 
segments from MCT-treated rats or on the response of 
the artery segment to EFS (Figure 4).  
 
Effect of L-NAME on noradrenaline-induced 






 M) evoked concentration-
dependent contractions of the pulmonary artery 
segments (Figure 5) with pD2 values of 6.70±0.11  
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Effect of 7NI, (10
-4
M), a selective inhibitor of inducible 
nitric oxide synthase, on EFS-induced contractions of 
pulmonary artery ring segments isolated from control (A) 
and monocrotaline-treated pulmonary hypertensive rats (B). 
 and  represent EFS-induced contractions in the absence 
and in the presence of 7NI, respectively. Each point on the 
graph is the mean S.E.M of 4 (monocrotaline-treated rats) 




Noradrenaline-induced contractions of pulmonary artery ring 
segments from control (A) and monocrotaline-treated 
pulmonary hypertensive (B) rats.  and  represent 
noradrenaline-induced contractions before and in the 
presence of –NAME (10-4M), respectively. Each point on the 
graph is the mean S.E.M of 5 (control rats) and 7 
(monocrotaline-treated rats) experiments.* - significantly 
different (p < 0.05) 
 
 
(n=5), and 7.00±0.04 (n=10) in control and 
monocrotaline treated rats respectively. L-NAME (10
-4
 
M) enhanced noradrenaline-induced contractions in 
artery segments from control and MCT-treated rats. 
The enhancement was greater in artery segments from 
MCT-treated rats (p<0.05) in the maximum contractile 
response to EFS of PA segments with intact 
endothelium from control and MCT-treated rats.  
 
DISCUSSION 
Even though the pulmonary artery is innervated by 
sympathetic nerves, which when stimulated produces 
an excitatory response, the effect of pulmonary 
hypertension on these responses has not been 
investigated. The main objective of the present study 
was therefore to investigate the effect of 
monocrotaline-induced pulmonary hypertension in rats 
on the excitatory response of the pulmonary artery to 
electrical field stimulation. In the present study, 
increased heart/body weight ratio (an index of cardiac 
hypertrophy) in rats treated with monocrotaline 
(compared with control rats) was taken as an indication 
of the development of pulmonary hypertension in these 
rats. Our results showed that electrical field stimulation 
of pulmonary artery segments from control rats 
produced reproducible and frequency-dependent 
contractions confirming previous reports in the 
literature (Cederqvist et al., 1991; Liu et al., 1991; 
Martinez et al., 1995; Segarra et al., 1999; Maclean and 
Morecroft, 2001). These contractions were almost 
abolished by phentolamine suggesting that they were 
predominantly adrenergic in nature. Similar 
reproducible and frequency-dependent contractions 
were also observed in artery segments from pulmonary 
hypertensive rats. These electrically induced 
contractions were significantly greater in artery 
segments from pulmonary hypertensive rats compared 
with similar preparations from control rats. 
Previous studies have shown that electrically-induced 
contractions of pulmonary artery segments are 
modulated by nitric oxide (Cederqvist et al., 1991; Liu 
et al., 1991; Martinez et al., 1995; Segarra et al., 1999; 
Maclean and Morecroft, 2001). This was based on the 
ability of NO synthase inhibitors to potentiate 
electrically-induced contractions in these preparations 
(Cederqvist et al., 1991; Liu et al., 1991; Martinez et 
al., 1995; Segarra et al., 1999; Maclean and Morecroft, 
2001) coupled with the fact that the potentiation was 
reversed by treatment with arginine. Endothelial 
dysfunction, characterized by impaired endothelium-
dependent relaxation of the pulmonary artery to 
acetylcholine, has been reported by several authors 
(Altiere et al., 1985; Mathew et al., 1995; Nakazawa et 
al., 1999; Ito et al., 2000; Mam et al., 2010). We 
therefore tested the possibility that the enhanced 
electrically-induced contraction in artery segments 
from monocrotaline-treated rats could have been due to 
impaired release of NO by the vascular endothelium. 
The results from preliminary experiments showed that 
EFS-induced contractions in control rats were 
potentiated by L-NAME confirming modulation of 
EFS-induced contractions by NO in agreement with 
previous reports in the literature (Cederqvist et al., 
1991; Liu et al., 1991; Martinez et al., 1995; Segarra et 
al., 1999; Maclean and Morecroft, 2001). The fact that 
the potentiating effect of L-NAME on EFS-induced 
contractions was lost in endothelium-denuded 
preparations would suggest a role for eNOS in this 
potentiation. Since L-NAME is a non-selective NOS 
inhibitor, we examined the effect of 7-NI, a selective 
inhibitor of neuronal NOS (nNOS) on EFS-induced 
contractions of the artery segments. It was observed 
that 7-NI had no effect on EFS-induced contractions 
confirming that the potentiating effect of L-NAME on 
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EFS-induced contractions was mediated through 
inhibition of eNOS. A role for inducible NOS (iNOs) 
can also be excluded since aminoguanidine, an 
inhibitor of iNOS did not cause vasoconstriction of the 
perfused pulmonary hypertensive rat lung preparation 
(Tyler et al., 1999). Therefore L-NAME was used to 
investigate the effect of pulmonary hypertension on 
EFS-induced contractions of pulmonary artery 
segments. The results showed that L-NAME 
potentiated EFS-induced contractions of artery 
segments isolated from MCT-treated rats and that L-
NAME did not differentiate between artery segments 
from control and monocrotaline-treated rats suggesting 
that modulation of EFS-induced contractions of the 
pulmonary artery was maintained in artery segments 
from monocrotaline-treated rats. In addition, L-NAME 
also potentiated NA-induced contractions of artery 
segments from control and MCT-treated rats. This is in 
contrast to failure by Mam et al. (2010) to demonstrate 
a potentiating effect of L-NAME on phenylephrine 
(PE)-induced contractions in MCT-treated rats even 
though it did potentiate PE-induced contractions in 
artery segments from chronically hypoxic rats, another 
experimental model of pulmonary hypertension. The 
role of NOS in the pathobiology of pulmonary 
hypertension is controversial. Many studies have 
reported impaired endothelium-dependent carbachol- 
induced relaxation of pulmonary artery segments and 
this has been interpreted as signifying impaired release 
of NO from the vascular endothelium (Nakazawa et al., 
1999; Ito et al., 2000). However, it has also been shown 
that relaxation of hypertensive main pulmonary artery 
segments induced by sodium nitroprusside, an 
endothelium-independent relaxant was also reduced 
(Wanstall et al., 1992, 1993; Mam et al., 2010) 
suggesting that the decreased relaxation may not 
necessarily be due to impaired NO release from the 
vascular endothelium. Studies on the effect of 
pulmonary hypertension on the expression of NOS 
have also yielded conflicting results. Thus while Sahara 
et al. (2012) and Cheng et al. (2005) reported decreased 
expression of NOS in pulmonary hypertensive rats, 
Kim et al. (2012) have reported an up-regulation of 
NOS expression following induction of pulmonary 
hypertension in rats. This has been confirmed by other 
workers (Tyler et al., 1999; Cho et al., 2009). The 
reason for the conflicting reports is not known. 
However, using quantitative immunocytochemistry 
techniques, it has been convincingly shown that the 
intensity of eNOS staining was greater in pulmonary 
arteries from pulmonary hypertensive rats compared 
with controls (Resta et al., 1997; Tyler et al., 1999). 
Resta et al. (1999) suggested that the reduced protein 
expression in the lungs, even when the expression was 
enhanced in the arteries, could be due to dilution of 
NOS by other components of the whole lung. The 
observation that L-NAME produced a greater increase 
in pulmonary vascular resistance in monocrotaline-
treated rats (Tyler et al., 1999; Leung et al., 2003) 
would support enhanced NOS expression in the 
pulmonary hypertensive rats. Our results indicating 
unaltered modulation of electrically-induced 
contractions of pulmonary artery segments isolated 




We conclude that pulmonary artery contractions to 
electrical field stimulation were enhanced in artery 
segments form pulmonary hypertensive rats and that 
the modulatory role of the vascular endothelium via 
release of nitric oxide was unaltered in these vessels. 
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